-
Kymera Therapeutics' (KYMR) "Buy" Rating Reiterated at Truist Financial
Source: Buzz FX / 01 Nov 2024 11:02:16 America/Chicago
Kymera Therapeutics' (KYMR) "Buy" Rating Reiterated at Truist Financial Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Kymera Therapeutics ( NASDAQ:KYMR - Get Free Report ) 's stock had its "buy" rating reiterated by
Read more...